6:01 PM
 | 
Sep 17, 2013
 |  BC Extra  |  Company News

AstraZeneca submits naloxegol NDA

Nektar Therapeutics (NASDAQ:NKTR) disclosed in an SEC filing that partner AstraZeneca plc (LSE:AZN; NYSE:AZN) submitted an NDA to FDA for naloxegol to treat opioid-induced...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >